Form 483

Vitalant Form 483, 2012-03-14

FDA issued a Form 483 to Vitalant on 2012-03-14 with 5 public-safe observations.

483· Form 483 issued5 observations

Vitalant · Montvale, United States · Issued March 14, 2012

Overview

  • 5 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

14 Mar 2012
21 CFR 606.20(b)

Qualifications of responsible personnel

Cited by Sarah M Forney, Jennifer Macmillan

14 Mar 2012
21 CFR 606.100(b)

Establish, maintain and follow manufacturing SOPs

Cited by Sarah M Forney, Jennifer Macmillan

14 Mar 2012
21 CFR 606.100(b)(4)

Relate products to the donor

Cited by Sarah M Forney, Jennifer Macmillan

14 Mar 2012
21 CFR 606.100(c)

Thorough investigations

Cited by Sarah M Forney, Jennifer Macmillan

14 Mar 2012
21 CFR 606.160(a)(1)

Concurrent documentation

Cited by Sarah M Forney, Jennifer Macmillan

Inspected site

VVitalantMontvale, United States

Inspection team

JMJennifer Macmillan

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 606.100(b)Cited across public-safe Form 483 observations1x
21 CFR 606.100(b)(4)Cited across public-safe Form 483 observations1x
21 CFR 606.100(c)Cited across public-safe Form 483 observations1x
21 CFR 606.160(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 606.20(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 5 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere